Tag U.S.

PACSGEAR Ramps Up for PACS 2.0

Oct13

PACSGEAR, the leading provider of imaging connectivity for electronic health records, announced an expanded strategy to combine medical images from all departments with electronic health records. The "PACS 2.0" initiative is the evolution of medical image connectivity to include integration with the electronic health record. In the past year, PACSGEAR has successfully integrated over 500,000 […]

The National Association Of Boards Of Pharmacy And Pfizer Partner To Educate Patients About The Flood Of Counterfeit Medicines Online

Oct12

Pfizer Inc. (NYSE: PFE) and the National Association of Boards of Pharmacy (NABP) are launching a new effort to draw attention to the risks associated with counterfeit prescription medicines and help patients learn how to safely buy medicines online. Prescription medicines are among the most counterfeited consumer goods. Worldwide sales of counterfeit medicines were estimated […]

Governor Announces Next Step in Implementation of Statewide Electronic Health Records

Oct11

CHICAGO Governor Quinn announced today the selection of InterSystems Corporation as the vendor assisting the state in the next stage of development of Illinois’ electronic health information system. After a competitive bidding process, the Illinois Office of Health Information Technology selected InterSystems to develop the technology infrastructure for the Illinois Health Information Exchange. The Exchange […]

Sembiosys and Tasly Pharmaceuticals Sign Multi-Product Commercialization and Platform Collaboration Agreement

Oct11

One of China's Largest Pharmaceutical Companies to Commercialize SemBioSys' Plant-Based Manufacturing Technology in Global Joint VentureCALGARY, Oct. 11, 2011 /PRNewswire/ – SemBioSys Genetics Inc. (TSX:SBS), today announced that it has signed a product and platform development collaboration agreement (the "Agreement") with Tasly Pharmaceuticals, Ltd ("Tasly") of Tianjin China and its wholly owned subsidiary Tasly U.S. […]

Sysmex Announces Newest Version of Clinical Laboratory Management Software

Oct11

Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, announces the release of the newest version of its Sysmex WAM? middleware software platform. The Sysmex WAM Management Reports Module features new tools such as ‘Point and click’ navigation which enable the user to quickly develop on-demand reports, facilitating management […]

Diversinet Strengthens Military Healthcare IT Expertise with Two Executive Advisory Board Appointments

Oct11

Diversinet Corp. (TSX Venture: DIV, OTCBB: DVNTF), a leader in "Connected and Protected" mobile healthcare communications, has appointed to its executive advisory board two experts in healthcare technology issues and applications related to the United States Department of Defense (DoD):? Dr. Hon Pak, previous President of the American Telemedicine Association and recently retired Chief Information […]

Watson Pharmaceuticals Announces Approval of Amphastar’s Generic LOVENOX

Oct8

Watson Pharmaceuticals, Inc. (NYSE: WPI) announced that Amphastar Pharmaceuticals, Inc., has received U.S. Food and Drug Administration ("FDA") approval of its Abbreviated New Drug Application (ANDA) for Enoxaparin Sodium Injection in the 100mg/mL and 150mg/mL strengths. Enoxaparin Sodium Injection is the generic equivalent to Sanofi-aventis’ LOVENOX, and is a low molecular weight heparin indicated in […]

Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX

Oct8

PARSIPPANY, N.J., Oct. 8, 2011 /PRNewswire/ Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that the United States District Court for the District of Massachusetts has granted a request by Momenta Pharmaceuticals, Inc. and Sandoz Inc. for a temporary restraining order (TRO) preventing Watson and Amphastar Pharmaceuticals, Inc. from marketing or selling Amphastar's Enoxaparin Sodium Injection […]

FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Teva’s $6.8 Billion Acquisition of Cephalon

Oct7

WASHINGTON, Oct. 7 The Federal Trade Commission issued the following news release:To protect competition in the market for prescription drugs, the Federal Trade Commission will require Teva Pharmaceutical Industries Ltd. to sell the rights and assets related to a generic cancer pain drug and a generic muscle relaxant, as a condition of its proposed $6.8 […]

Watson Confirms EMBEDA(R) Patent Challenge

Oct7

PARSIPPANY, N.J., Oct. 7, 2011 /PRNewswire/ Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Morphine Sulfate and Naltrexone Hydrochloride Extended-release Capsules 30 mg/1.2 mg, 50 mg/2 mg, 60 mg/2.4 […]